Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline
Metadatos
Mostrar el registro completo del ítemAutor
Ayala, Alba; Triviño Juárez, José Matías; Forjaz, Maria João; Rodríguez-Blázquez, Carmen; Rojo-Abuin, José-Manuel; Martínez-Martín, PabloEditorial
Frontiers Media S.A.
Materia
Parkinson's disease disease global severity predictive model
Fecha
2017-10-30Referencia bibliográfica
Ayala A, Triviño-Juárez JM, Forjaz MJ, Rodríguez-Blázquez C, Rojo-Abuin JM, Martínez-Martín P. Parkinson's Disease Severity at 3 Years Can Be Predicted from Non-Motor Symptoms at Baseline. Front Neurol. 2017 Oct 30;8:551. doi: 10.3389/fneur.2017.00551. PMID: 29163328; PMCID: PMC5674937.
Patrocinador
The Spanish Longitudinal PD Patient Study (Estudio longitudinal de pacientes con enfermedad de Parkinson) was supported by an Intramural Research Programme grant from the Carlos III Institute of Health (Code: EPY1271/05). Partial funding was also obtained from the following grants: ENVACES (MINECO/FEDER/UE, ref. CSO2015-64115-R) and ENCAGE-CM (Comunidad de Madrid, ref. S2015/HUM-3367).Resumen
Objective: The aim of this study is to present a predictive model of Parkinson's disease (PD) global severity, measured with the Clinical Impression of Severity Index for Parkinson's Disease (CISI-PD).
Methods: This is an observational, longitudinal study with annual follow-up assessments over 3 years (four time points). A multilevel analysis and multiple imputation techniques were performed to generate a predictive model that estimates changes in the CISI-PD at 1, 2, and 3 years.
Results: The clinical state of patients (CISI-PD) significantly worsened in the 3-year follow-up. However, this change was of small magnitude (effect size: 0.44). The following baseline variables were significant predictors of the global severity change: baseline global severity of disease, levodopa equivalent dose, depression and anxiety symptoms, autonomic dysfunction, and cognitive state. The goodness-of-fit of the model was adequate, and the sensitive analysis showed that the data imputation method applied was suitable.
Conclusion: Disease progression depends more on the individual's baseline characteristics than on the 3-year time period. Results may contribute to a better understanding of the evolution of PD including the non-motor manifestations of the disease.